zoledronic acid has been researched along with Thrombocytopenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Karpuz, S | 1 |
Hamersky, J; Jimenez, PT; Neto, RLALT; Smith, AA; Soileau, AM | 1 |
Cushman, T; Donthireddy, V; Kulkarni, P; Rao, S | 1 |
Chahine, GY; Farhat, FS; Ghosn, MG; Kattan, JG; Moukadem, WT; Nasr, FL; Yazbeck, NJ; Younes, FC | 1 |
1 trial(s) available for zoledronic acid and Thrombocytopenia
Article | Year |
---|---|
Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Fatigue; Humans; Hypocalcemia; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Zoledronic Acid | 2008 |
3 other study(ies) available for zoledronic acid and Thrombocytopenia
Article | Year |
---|---|
Zoledronic acid-induced severe lymphopenia.
Topics: Acute-Phase Reaction; Anemia; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Lymphopenia; Male; Osteoporosis; Thrombocytopenia; Zoledronic Acid | 2023 |
Doxorubicin and zoledronate treatment in a dog with hemophagocytic histiocytic sarcoma.
Topics: Animals; Dog Diseases; Dogs; Doxorubicin; Histiocytic Sarcoma; Hyperbilirubinemia; Hypoalbuminemia; Lomustine; Male; Thrombocytopenia; Zoledronic Acid | 2023 |
Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
Topics: Aged; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Osteoporosis; Platelet Count; Remission, Spontaneous; Thrombocytopenia; Zoledronic Acid | 2016 |